Department of Biological Systems Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska 68583-0726, USA.
Mol Ther. 2011 Dec;19(12):2144-51. doi: 10.1038/mt.2011.161. Epub 2011 Aug 9.
Inefficient gene delivery is a critical factor limiting the use of nonviral methods in therapeutic applications including gene therapy and tissue engineering. There have been few efforts to understand or engineer the molecular signaling pathways that dictate the efficacy of gene transfer. Microarray analysis was used to determine endogenous gene expression profiles modulated during nonviral gene transfer. Nonviral DNA lipoplexes were delivered to HEK 293T cells. Flow cytometry was used to isolate a population of transfected cells. Expression patterns were compared between transfected and nontransfected samples, which revealed three genes that were significantly upregulated in transfected cells, including RAP1A, a GTPase implicated in integrin-mediated cell adhesion, and HSP70B', a stress-inducible gene that may be important for maintaining cell viability. Furthermore, RAP1A was also significantly upregulated in untransfected cells that were exposed to lipoplexes but that had not expressed the transgene as compared to control, untreated cells. Transfection in the presence of activators of upregulated genes was enhanced, demonstrating the principle of altering endogenous gene expression profiles to enhance transfection. With a greater understanding of signaling pathways involved in gene delivery, more efficient nonviral delivery schemes capitalizing on endogenous factors can be developed to advance therapeutic applications.
基因传递效率低下是限制非病毒方法在治疗应用(包括基因治疗和组织工程)中应用的关键因素。目前,人们很少努力去理解或设计决定基因转移效率的分子信号通路。我们使用微阵列分析来确定在非病毒基因传递过程中调节的内源性基因表达谱。将非病毒 DNA 脂质体转染到 HEK 293T 细胞中。使用流式细胞术从转染的细胞中分离出一个群体。将转染和未转染样本之间的表达模式进行比较,结果显示三个基因在转染细胞中显著上调,包括 RAP1A,这是一种参与整合素介导的细胞黏附的 GTPase,以及 HSP70B',这是一种应激诱导的基因,可能对维持细胞活力很重要。此外,与对照未处理细胞相比,暴露于脂质体但未表达转基因的未转染细胞中 RAP1A 的表达也显著上调。在上调基因的激活剂存在下进行转染可增强转染效率,证明了改变内源性基因表达谱以增强转染的原理。通过更深入地了解基因传递中涉及的信号通路,可以开发出更有效的利用内源性因素的非病毒传递方案,以推进治疗应用。